Clinical case study challenges established paradigms on permanent cognitive and motor decline in age-related degenerative diseases.
Capsules containing donor stool microbes improved sleep efficiency and reduced nighttime wakefulness in adults with chronic insomnia.
Personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to walk independently for the first time.
Prions can turn the body’s own proteins into a threat, and studying this group of diseases could help us better understand dementia.
Seizures can race through the brain in seconds, making them difficult to capture in detail. To overcome this challenge, researchers have developed a new high-resolution light-sheet imaging system that is fast enough to image seizure propagation in the brain of a larval zebrafish in 3D.
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue while limiting damage to surrounding skin. But PDT has a fundamental challenge: both the drug and the light must reach the same area of tissue.
Casana announced today that it launched the Smart Seat, a smart toilet seat capable of measuring a range of metrics.
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of cells that mimic structural and functional features of an organ, tumor or other tissue. The advances represent progress in precision medicine and point to the more routine use of tumor organoids as models for evaluating and optimizing cancer treatments.
BRIJ-SEAL creates a protective, flexible seal over the incision that lasts for up to 14 days.
A machine learning tool that analyzes information already captured in a child’s electronic health record helped pediatricians more accurately assess asthma risk in standardized clinical case scenarios, according to a pilot randomized clinical trial led by a Regenstrief Institute researcher.